Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,600
Sort by:

U.S. Hepatitis Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2027)

US$ 1,500.00

The United States hepatitis vaccines market is projected to boost over the forecast period of 2021 to 2027. This new market report provides a comprehensive analysis of the fast-evolving, high-growth...

May 2021 70 pages

U.S. Influenza (Flu) Vaccines Market – Growth, Demand, Trends, Opportunity, Forecasts (2021 – 2028)

US$ 2,500.00

The United States influenza vaccines market size to cross US$ 5.5 Billion by 2028. This new market report presents an inclusive study of the entire United States influenza vaccines market. The report...

May 2021 205 pages

Investigation Report on China's Abiraterone Market 2021-2025

US$ 2,600.00

Abiraterone is a CYP17 inhibitor, which is mainly clinically used to treat prostate cancer patients. Its product ZYTIGA was developed by Janssen-Cilag International NV(a subsidiary of Johnson & Johnso...

May 2021 50 pages

Investigation Report on China's Butylphthalide Market 2021-2025

US$ 2,600.00

Butylphthalide, developed by CSPC Enbipu Pharmaceutical Co. Ltd is used to treat mild to moderate acute ischemic stroke. Its soft capsule was approved in China in 2005, and its injection was approved...

May 2021 50 pages

Investigation Report on China's Dasatinib Market 2021-2025

US$ 2,600.00

Dasatinib, developed by Bristol-Myers Squibb, is an anti-tumor drug. It was first approved by the FDA in 2006 for the treatment of adult patients with Philadelphia chromosome-positive (Ph+) chronic my...

May 2021 50 pages

Investigation Report on China's Dolutegravir Market 2021-2025

US$ 2,600.00

Dolutegravir was developed by GlaxoSmithKline for the treatment of HIV-infected adults and children over 12 years old. Its product TIVICAY was approved in China in 2016 and was approved for children's...

May 2021 50 pages

Investigation Report on China's Esomeprazole Market 2021-2025

US$ 2,600.00

Esomeprazole is a proton pump inhibitor (PPI), which can effectively inhibit gastric acid secretion. It is clinically used to treat gastric acid-related diseases such as gastroesophageal reflux diseas...

May 2021 50 pages

Investigation Report on China's Golimumab Market 2021-2025

US$ 2,600.00

Golimumab is an immunosuppressive medication that can effectively regulate inflammation and bone metabolism. The trade name of Golimumab is SIMPONI, which was developed by Janssen Biologics BV. Its pr...

May 2021 50 pages

Investigation Report on China's Paclitaxel Market 2021-2025

US$ 2,600.00

Paclitaxel is a chemotherapeutic tumor drug used to treat metastatic breast cancer after failure of combination chemotherapy or relapse within 6 months after adjuvant chemotherapy. Its product, develo...

May 2021 50 pages

Investigation Report on China's Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) 2021-2025

US$ 2,600.00

Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) is an effective drug for the prevention and treatment of neutropenia or deficiency caused by tumor radiotherapy or chemo...

May 2021 50 pages

Investigation Report on China's Piperacillin and Tazobactam Market 2021-2025

US$ 2,600.00

Piperacillin and Tazobactam is a compound anti-infective drug composed of piperacillin (semi-synthetic penicillin antibiotic) and tazobactam (?-lactamase inhibitor). It is suitable for moderate and se...

May 2021 50 pages

Investigation Report on China's Propofol Market 2021-2025

US$ 2,600.00

Propofol is a short-acting intravenous anesthetic. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is als...

May 2021 50 pages

Investigation Report on China's Tiotropium Bromide Market 2021-2025

US$ 2,600.00

Tiotropium Bromide, developed by Boehringer Ingelheim International GmbH, is used to treat chronic obstructive pulmonary disease (COPD). Its product SPIRIVA was approved in China in 2006. In 2017, Tio...

May 2021 50 pages

Investigation Report on China's Tocilizumab Market 2021-2025

US$ 2,600.00

The trade name of Tocilizumab is ACTEMRA, which was developed by Roche Pharma (Schweiz) AG. In 2013, its product was firstly approved in China and its indication is RA. Tocilizumab was approved in Chi...

May 2021 50 pages

Investigation Report on China's Voriconazole Market 2021-2025

US$ 2,600.00

Voriconazole is used to treat progressive, potentially life-threatening fungal infections. Its product was developed by Pfizer. It was approved in China in 2004. By 2020, there are 11 manufacturers of...

May 2021 50 pages

Investigation Report on Chinese Compound Amino Acid Market 2021-2025

US$ 2,600.00

Compound Amino Acid is clinically used for patients with insufficient protein intake, malabsorption, and other amino acids that cannot meet the requirements of body metabolism. It was developed by Jap...

May 2021 50 pages

Global Antipsychotic Drugs Market Size study, Antipsychotic Drugs Market by Drug Class (First Generation, Second Generation, Third Generation and Others), by Application (Schizophrenia, Dementia, Bipolar and Unipolar Depression) and Regional Forecasts 2021-2027

US$ 3,000.00

Global Antipsychotic Drugs Market is valued approximately USD 12.67 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.95% over the forecast period 2021-2027. A “psyc...

May 2021 200 pages

Drug Testing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Instruments, Rapid Testing Devices, Services), By Sample Type, By Drug Type, By End Use, By Region, And Segment Forecasts, 2021 - 2028

US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Drug Testing Market Growth & Trends The global drug testing market size is expected to reach USD 11.7 billion by 2028, according...

May 2021 120 pages

Investigation Report on China's Dulaglutide Market 2021-2025

US$ 2,600.00

Description Dulaglutide is a weekly long-acting GLP-1 receptor agonist developed by Eli Lilly and was approved to enter China in 2019. Dulaglutide is suitable for the blood glucose control of adult pa...

May 2021 50 pages

Investigation Report on China's Funeral Market 2021-2025

US$ 2,600.00

DESCRIPTION The funeral and interment industry can be divided into four parts from the perspective of service content: funeral services, disposal of remains, cemetery services, and other funeral produ...

May 2021 50 pages

Investigation Report on China's Palbociclib Market 2021-2025

US$ 2,600.00

Description Palbociclib is the world's first selective inhibitor of CDK 4/6 launched by Pfizer. By inhibiting CDK 4/6, Palbociclib restores cell cycle control, thereby blocking tumor cell proliferatio...

May 2021 50 pages

Investigation Report on China's Ustekinumab Market 2021-2025

US$ 2,600.00

Ustekinumab is a monoclonal antibody medication developed by Janssen Pharmaceuticals. It is mainly used to treat psoriasis, Crohn's disease, and ulcerative colitis. Janssen’s Ustekinumab, STELARA was...

May 2021 50 pages

Investigation Report on Chinese Salmeterol/Ticasone Market 2021-2025

US$ 2,600.00

Description Salmeterol/Ticasone is a compound medication used in regular treatment of asthma and chronic obstructive pulmonary disease (COPD). Its original drug was developed by GlaxoSmithKline. In 20...

May 2021 50 pages

Global Companion Animal Vaccine Market Size study, by Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Technologies), by Animal Type (Dogs, Cats, Other Animal Types ), and Regional Forecasts 2021-2027

US$ 3,000.00

Global Companion Animal Vaccine Market is valued at approximately USD 8.0 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.2 % over the forecast period 2021-2027. T...

May 2021 200 pages

Global Pharmaceutical Logistics Market Size study, by Product Type (Cold Chain Logistics, Non-cold Chain Logistics), Components (Storage, Transportation, Monitoring Components) and Regional Forecasts 2021-2027

US$ 3,000.00

Global Pharmaceutical Logistics Market is valued approximately USD 73.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.6 % over the forecast period 2021-2027. Pha...

May 2021 200 pages

India Large Volume Parenteral Market Size, Share & Trends Analysis Report By Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), By Volume, By End Use, And Segment Forecasts, 2021 - 2028

US$ 5,950.00

The India large volume parenterals (LVP) market size is expected to reach USD 121.7 ... drugs is responsible for growing demand for LVP. Parenterally administered drugs gain quick access to ... in terms of volume and 14th in terms of value in global rankings By application, the India LVP market is categorized into ...

May 2021 150 pages

Breast Cancer Treatment Drug Markets in China

US$ 4,000.00

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high...

May 2021 256 pages

Pharmaceutical Contract Manufacturing Global Market – Forecast To 2027

US$ 4,950.00

... role in securing client relationships that can lead to commercial scale manufacturing contracts. Pharmaceutical contract manufacturing market by application is segmented as Oncology, Central nervous system, Cardiovascular disorder, Infectious ...

May 2021 531 pages

Global BCG Vaccine Market Size study, by Type (Immune BCG and Therapy BCG) Demographics (Pediatrics (0-18 Years), Adults (19-35 Years)) Application (Hospitals, Clinics, Others) and Regional Forecasts 2020-2027

US$ 3,000.00

Global BCG Vaccine Market is valued approximately at USD 23.25 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.53% over the forecast period 2020-2027. The Bacillu...

May 2021 200 pages

Global Glass Vaccine Vial Market Size study, by Product Type (Molded Glass Vial, Tubular Glass Vial) Application (Preventive Vaccine, Therapeutic Vaccine) and Regional Forecasts 2020-2027

US$ 3,000.00

Global Glass Vaccine Vial Market is valued approximately at USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2027.. Glass h...

May 2021 200 pages

Global Hepatitis A Vaccine Market Size study, by Product Type (Inactivated vaccine and Live attenuated vaccine) Application (Government Institution, Private Sector and Other) and Regional Forecasts 2020-2027

US$ 3,000.00

Global Hepatitis A Vaccine Market is valued approximately at USD 672.21 million in 2019 and is anticipated to grow with a growth rate of more than 2.1% over the forecast period 2020-2027. The Hepatit...

May 2021 200 pages

Global Vaccine Refrigerators Market Size study, by Product (Vaccine stainless steel refrigerators, vaccine dual-temperature refrigerators, vaccine under-counter refrigerators, solar vaccine refrigerators, and others) by End-User (Hospitals, blood banks, pharmaceutical companies and academic & research institutes) and Regional Forecasts 2020-2027

US$ 3,000.00

Global Vaccine Refrigerators Market is valued approximately USD 421 million in 2019 and is anticipated to grow with a healthy growth rate of more than 6.1 % over the forecast period 2020-2027. Vaccin...

May 2021 200 pages

Acute respiratory distress syndrome (ARDS) - Pipeline Insight, 2021

US$ 2,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Acute Respiratory Distress Syndrome The report also ...

May 2021 150 pages

Ankylosing Spondylitis - Pipeline Insight, 2021

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ankylosing Spondylitis (Bekhterev's Disease) The report also ...

May 2021 80 pages

Anthrax - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Anthrax - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anthrax development. The report provides detailed ...

May 2021 60 pages

Aplastic Anemia - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Aplastic Anemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Aplastic Anemia development. The report provides ...

May 2021 60 pages

Bacteremia - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Bacteremia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bacteremia development. The report provides detailed ...

May 2021 60 pages

Diabetic gastroparesis - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Diabetic Gastroparesis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Gastroparesis development. The report provides ...

May 2021 70 pages

Gastrointestinal Stromal Tumors - Pipeline Insight, 2021

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Gastrointestinal Stromal Tumor (GIST) The report also ...

May 2021 60 pages

Vitiligo - Pipeline Insight, 2021

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Vitiligo - Pipeline Insight, 2019 The report also ...

May 2021 70 pages

Axial spondyloarthritis - Pipeline Insight, 2021

US$ 2,000.00

... clients within 48 Hours 'Axial Spondyloarthritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Axial Spondyloarthritis development. The report provides ...

May 2021 80 pages

Bacterial vaginosis - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Bacterial Vaginosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bacterial Vaginosis development. The report provides ...

May 2021 60 pages

Hepatitis D - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Hepatitis D - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis D development. The report provides ...

May 2021 60 pages

Hyperphosphatemia - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Hyperphosphatemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperphosphatemia development. The report provides detailed ...

May 2021 60 pages

Influenza A virus H5N1 subtype - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Influenza A Infections The report also ...

May 2021 60 pages

Kaposi's sarcoma - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Kaposi's Sarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Kaposi's Sarcoma development. The report provides ...

May 2021 60 pages

Nocturia - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Nocturia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nocturia development. The report provides detailed ...

May 2021 60 pages

Nonalcoholic Steatohepatitis - Pipeline Insight, 2021

US$ 3,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Alcoholic Steatohepatitis (NASH) The report also ...

May 2021 230 pages

Open-angle glaucoma - Pipeline Insight, 2021

US$ 2,000.00

... clients within 72 Hours 'Open-Angle Glaucoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Open-Angle Glaucoma development. The report provides ...

May 2021 80 pages

Filters

Search

Categories

154
14,836
12,081
344
72
1,113

Publishers

72
1
1,760
342
155
531
292
33
4
2,060
635
92
3,251
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
141
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
82
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
25,994

Price

—

Date

—

Pages

—

Offers

44
5
1